EUR 19.26
(-1.03%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 785.69 Million EUR | 4.3% |
2022 | 753.27 Million EUR | 2.9% |
2021 | 732.07 Million EUR | 2.78% |
2020 | 712.29 Million EUR | -12.81% |
2019 | 816.9 Million EUR | 2.81% |
2018 | 794.61 Million EUR | -1.73% |
2017 | 808.63 Million EUR | 4.14% |
2016 | 776.46 Million EUR | 58.49% |
2015 | 489.91 Million EUR | 19.63% |
2014 | 409.5 Million EUR | 4.84% |
2013 | 390.59 Million EUR | -3.38% |
2012 | 404.25 Million EUR | 6.99% |
2011 | 377.83 Million EUR | 7.16% |
2010 | 352.57 Million EUR | 5.1% |
2009 | 335.47 Million EUR | 4.58% |
2008 | 320.78 Million EUR | 4.99% |
2007 | 305.54 Million EUR | 5.58% |
2006 | 289.4 Million EUR | 7.4% |
2005 | 269.47 Million EUR | 8.88% |
2004 | 247.48 Million EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 424.92 Million EUR | 0.0% |
2023 FY | 785.69 Million EUR | 4.3% |
2023 Q2 | 378.63 Million EUR | 0.0% |
2023 Q4 | 415.86 Million EUR | 0.0% |
2022 FY | 753.27 Million EUR | 2.9% |
2022 Q4 | 382.2 Million EUR | 0.0% |
2022 Q2 | 371.07 Million EUR | 0.0% |
2021 Q4 | 368.95 Million EUR | 0.0% |
2021 Q2 | 363.11 Million EUR | 0.0% |
2021 FY | 732.07 Million EUR | 2.78% |
2020 Q4 | 348.64 Million EUR | 0.0% |
2020 Q2 | 363.65 Million EUR | 0.0% |
2020 FY | 712.29 Million EUR | -12.81% |
2019 Q4 | 416.34 Million EUR | 0.0% |
2019 Q2 | 400.56 Million EUR | 0.0% |
2019 FY | 816.9 Million EUR | 2.81% |
2018 Q4 | 403.89 Million EUR | 0.0% |
2018 Q2 | 390.72 Million EUR | 0.0% |
2018 FY | 794.61 Million EUR | -1.73% |
2017 FY | 808.63 Million EUR | 4.14% |
2017 Q2 | 408.88 Million EUR | 0.0% |
2017 Q4 | 399.74 Million EUR | 0.0% |
2016 FY | 776.46 Million EUR | 58.49% |
2016 Q2 | 380.16 Million EUR | 0.0% |
2016 Q4 | 396.3 Million EUR | 0.0% |
2015 Q4 | 261.53 Million EUR | 0.0% |
2015 Q2 | 228.37 Million EUR | 0.0% |
2015 FY | 489.91 Million EUR | 19.63% |
2014 FY | 409.5 Million EUR | 4.84% |
2014 Q4 | 206.61 Million EUR | 0.0% |
2014 Q2 | 202.89 Million EUR | 0.0% |
2013 Q2 | 193.26 Million EUR | 0.0% |
2013 Q4 | 197.33 Million EUR | 0.0% |
2013 FY | 390.59 Million EUR | -3.38% |
2012 Q1 | 101.07 Million EUR | 0.0% |
2012 FY | 404.25 Million EUR | 6.99% |
2012 Q4 | 97.64 Million EUR | -3.39% |
2012 Q3 | 101.07 Million EUR | 0.0% |
2012 Q2 | 101.07 Million EUR | 0.0% |
2011 FY | 377.83 Million EUR | 7.16% |
2011 Q3 | 94.45 Million EUR | 0.0% |
2011 Q1 | 94.45 Million EUR | 0.0% |
2011 Q2 | 94.45 Million EUR | 0.0% |
2011 Q4 | 101.07 Million EUR | 7.0% |
2010 Q1 | 88.14 Million EUR | 0.0% |
2010 Q3 | 88.14 Million EUR | 0.0% |
2010 FY | 352.57 Million EUR | 5.1% |
2010 Q4 | 94.45 Million EUR | 7.16% |
2010 Q2 | 88.14 Million EUR | 0.0% |
2009 Q3 | 83.86 Million EUR | 0.0% |
2009 Q1 | 83.86 Million EUR | 0.0% |
2009 FY | 335.47 Million EUR | 4.58% |
2009 Q4 | 88.14 Million EUR | 5.1% |
2009 Q2 | 83.86 Million EUR | 0.0% |
2008 Q3 | 80.19 Million EUR | 0.0% |
2008 Q2 | 80.19 Million EUR | 0.0% |
2008 Q1 | 80.19 Million EUR | 0.0% |
2008 FY | 320.78 Million EUR | 4.99% |
2008 Q4 | 83.86 Million EUR | 4.58% |
2007 Q4 | 80.19 Million EUR | 4.99% |
2007 Q3 | 76.38 Million EUR | 0.0% |
2007 Q2 | 76.38 Million EUR | 0.0% |
2007 Q1 | 76.38 Million EUR | 0.0% |
2007 FY | 305.54 Million EUR | 5.58% |
2006 Q1 | 72.35 Million EUR | 0.0% |
2006 FY | 289.4 Million EUR | 7.4% |
2006 Q3 | 72.35 Million EUR | 0.0% |
2006 Q2 | 72.35 Million EUR | 0.0% |
2006 Q4 | 76.38 Million EUR | 5.58% |
2005 Q1 | 67.36 Million EUR | 0.0% |
2005 Q4 | 72.35 Million EUR | 7.4% |
2005 Q3 | 67.36 Million EUR | 0.0% |
2005 Q2 | 67.36 Million EUR | 0.0% |
2005 FY | 269.47 Million EUR | 8.88% |
2004 FY | 247.48 Million EUR | 0.0% |
2004 Q2 | 61.87 Million EUR | 0.0% |
2004 Q1 | 61.87 Million EUR | 0.0% |
2004 Q3 | 61.87 Million EUR | 0.0% |
2004 Q4 | 67.36 Million EUR | 8.88% |
2003 Q4 | 61.87 Million EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Affluent Medical SA | 1.22 Million EUR | -64090.359% |
Bluelinea Société Anonyme | 9826.00 EUR | -7995930.938% |
Carmat SA | 2.84 Million EUR | -27487.43% |
Diagnostic Medical Systems S.A. | 42.15 Million EUR | -1763.901% |
Euromedis Groupe | 37.42 Million EUR | -1999.168% |
Eurobio Scientific Société anonyme | 130.64 Million EUR | -501.388% |
Ikonisys S.A. | 448.55 Thousand EUR | -175059.456% |
Implanet S.A. | 7.44 Million EUR | -10450.423% |
Median Technologies SA | 22.22 Million EUR | -3435.004% |
SpineGuard SA | 4.31 Million EUR | -18117.64% |
Theraclion SA | 1.82 Million EUR | -43017.163% |
Euroapi S.A. | 1.01 Billion EUR | 22.888% |